Overview of Regulatory Guidelines Related to Methods and Models for Small Populations
Laurens Sluijterman, Letao Li, Kristin E. Karlsson, Vincent Damotte, Sarah Zohar, Kit Roes, Joanna IntHout · 2026
Read Overview of Regulatory Guidelines Related to Methods and Models for Small Populations by Laurens Sluijterman, Letao Li, Kristin E. Karlsson, Vincent Damotte, Sarah Zohar, Kit Roes, Joanna IntHout (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13660450.txt.
Description
Laurens Sluijterman and co-authors review regulator guidance for small population trials in a 2026 paper. Rare diseases leave few patients for the large trials regulators usually expect. Guidance from European, American, and global bodies covers workarounds for that problem. The review groups those approaches and checks where modeling fits in.
Approaches fall into three sets: grow the sample, adapt the design, or borrow outside data. Clinical context drives which tools are acceptable in each case, the authors stress. Two gaps stand out in the guidance they reviewed. Advice on Bayesian methods is thin, and mixing trial data with real world data lacks clear rules.
Catalog record
| CREATOR | Laurens Sluijterman, Letao Li, Kristin E. Karlsson, Vincent Damotte, Sarah Zohar, Kit Roes, Joanna IntHout |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |